Coloplast A/S - Asset Resilience Ratio
Coloplast A/S (COLO-B) has an Asset Resilience Ratio of -0.07% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check COLO-B capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2023)
This chart shows how Coloplast A/S's Asset Resilience Ratio has changed over time. See COLO-B net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Coloplast A/S's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Coloplast A/S market capitalisation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Dkr0.00 | 0% |
| Short-term Investments | Dkr-33.00 Million | -0.07% |
| Total Liquid Assets | Dkr-33.00 Million | -0.07% |
Asset Resilience Insights
- Limited Liquidity: Coloplast A/S maintains only -0.07% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Coloplast A/S Industry Peers by Asset Resilience Ratio
Compare Coloplast A/S's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
|
Covalon Technologies Ltd.
V:COV |
Medical Instruments & Supplies | 6.33% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Trajan Group Holdings Ltd
AU:TRJ |
Medical Instruments & Supplies | 0.29% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
Annual Asset Resilience Ratio for Coloplast A/S (2002–2023)
The table below shows the annual Asset Resilience Ratio data for Coloplast A/S.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-09-30 | -0.08% | Dkr-39.00 Million ≈ $-6.10 Million |
Dkr48.16 Billion ≈ $7.53 Billion |
-0.71pp |
| 2022-09-30 | 0.63% | Dkr219.00 Million ≈ $34.26 Million |
Dkr34.96 Billion ≈ $5.47 Billion |
-0.80pp |
| 2021-09-30 | 1.43% | Dkr226.00 Million ≈ $35.36 Million |
Dkr15.84 Billion ≈ $2.48 Billion |
-0.51pp |
| 2020-09-30 | 1.94% | Dkr262.00 Million ≈ $40.99 Million |
Dkr13.50 Billion ≈ $2.11 Billion |
-0.52pp |
| 2019-09-30 | 2.46% | Dkr313.00 Million ≈ $48.97 Million |
Dkr12.73 Billion ≈ $1.99 Billion |
-0.18pp |
| 2018-09-30 | 2.63% | Dkr310.00 Million ≈ $48.50 Million |
Dkr11.77 Billion ≈ $1.84 Billion |
+0.02pp |
| 2017-09-30 | 2.61% | Dkr315.00 Million ≈ $49.28 Million |
Dkr12.05 Billion ≈ $1.89 Billion |
-1.83pp |
| 2016-09-30 | 4.44% | Dkr489.00 Million ≈ $76.51 Million |
Dkr11.01 Billion ≈ $1.72 Billion |
-0.36pp |
| 2015-09-30 | 4.80% | Dkr519.00 Million ≈ $81.20 Million |
Dkr10.82 Billion ≈ $1.69 Billion |
-1.17pp |
| 2014-09-30 | 5.96% | Dkr619.00 Million ≈ $96.85 Million |
Dkr10.38 Billion ≈ $1.62 Billion |
+2.04pp |
| 2013-09-30 | 3.92% | Dkr367.00 Million ≈ $57.42 Million |
Dkr9.36 Billion ≈ $1.47 Billion |
-2.42pp |
| 2012-09-30 | 6.34% | Dkr645.00 Million ≈ $100.91 Million |
Dkr10.18 Billion ≈ $1.59 Billion |
+0.18pp |
| 2011-09-30 | 6.16% | Dkr568.00 Million ≈ $88.87 Million |
Dkr9.22 Billion ≈ $1.44 Billion |
+6.15pp |
| 2010-09-30 | 0.01% | Dkr1.00 Million ≈ $156.46K |
Dkr7.77 Billion ≈ $1.22 Billion |
+0.00pp |
| 2009-09-30 | 0.01% | Dkr1.00 Million ≈ $156.46K |
Dkr7.96 Billion ≈ $1.25 Billion |
-3.85pp |
| 2003-09-30 | 3.86% | Dkr207.00 Million ≈ $32.39 Million |
Dkr5.36 Billion ≈ $838.61 Million |
+3.84pp |
| 2002-09-30 | 0.02% | Dkr1.00 Million ≈ $156.46K |
Dkr4.49 Billion ≈ $702.34 Million |
-- |
About Coloplast A/S
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, wh… Read more